Trial intelligence / Profile preview

S-1 Plus Irinotecan in Advanced Colorectal Cancer

NCT00209651Phase 2Unknown

Sponsor
Hokkaido Gastrointestinal Cancer Study Group
Start
Jan 2004
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tegafur in colorectal cancer (CRC), sponsored by Hokkaido Gastrointestinal Cancer Study Group. Status: unknown.

02

Drugs

tegafur
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT00209651.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00209651.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call